As of 2025-05-20, the Fair Value of Capstone Therapeutics Corp (CAPS) is -3.46 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.09 USD, the upside of Capstone Therapeutics Corp is -265.76%.
With the market price of 2.09 USD and our fair value calculation, Capstone Therapeutics Corp (CAPS) is not a good investment. Investing in CAPS stocks now will result in a potential loss of 265.76%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2015-12-31 | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 5Y Avg | |
| Net income | -2.77 | -0.66 | -1.75 | -0.38 | -2.07 | -1.53 |
| YoY growth | 33.50% | 76.07% | -164.71% | 78.35% | -445.53% | -84.46% |
| Market Cap (mil) | 10.85 |
| P/E | |
| Forward P/E |
| EPS | -0.69 |
| Avg earnings growth rate | -84.46% |
| TTM earnings | -3.60 |